312 related articles for article (PubMed ID: 27827367)
1. CD301b+ dendritic cells stimulate tissue-resident memory CD8+ T cells to protect against genital HSV-2.
Shin H; Kumamoto Y; Gopinath S; Iwasaki A
Nat Commun; 2016 Nov; 7():13346. PubMed ID: 27827367
[TBL] [Abstract][Full Text] [Related]
2. Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8
Lopes PP; Todorov G; Pham TT; Nesburn AB; Bahraoui E; BenMohamed L
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437976
[TBL] [Abstract][Full Text] [Related]
3. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic prime/pull vaccination of HSV-2-infected guinea pigs with the ribonucleotide reductase 2 (RR2) protein and CXCL11 chemokine boosts antiviral local tissue-resident and effector memory CD4
Quadiri A; Prakash S; Dhanushkodi NR; Singer M; Zayou L; Shaik AM; Sun M; Suzer B; Lau LSL; Chilukurri A; Vahed H; Schaefer H; BenMohamed L
J Virol; 2024 May; 98(5):e0159623. PubMed ID: 38587378
[TBL] [Abstract][Full Text] [Related]
5. Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract.
Tang VA; Rosenthal KL
J Reprod Immunol; 2010 Dec; 87(1-2):39-44. PubMed ID: 20688399
[TBL] [Abstract][Full Text] [Related]
6. Estradiol Enhances Antiviral CD4
Bagri P; Ghasemi R; McGrath JJC; Thayaparan D; Yu E; Brooks AG; Stämpfli MR; Kaushic C
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028712
[TBL] [Abstract][Full Text] [Related]
7. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
[TBL] [Abstract][Full Text] [Related]
8. A Fixed Spatial Structure of CD8
Schiffer JT; Swan DA; Roychoudhury P; Lund JM; Prlic M; Zhu J; Wald A; Corey L
J Immunol; 2018 Sep; 201(5):1522-1535. PubMed ID: 30045971
[TBL] [Abstract][Full Text] [Related]
9. Tissue-Resident-Memory CD8
Peng T; Phasouk K; Sodroski CN; Sun S; Hwangbo Y; Layton ED; Jin L; Klock A; Diem K; Magaret AS; Jing L; Laing K; Li A; Huang ML; Mertens M; Johnston C; Jerome KR; Koelle DM; Wald A; Knipe DM; Corey L; Zhu J
Front Immunol; 2021; 12():735643. PubMed ID: 34552595
[TBL] [Abstract][Full Text] [Related]
10. CXCL17 Chemokine-Dependent Mobilization of CXCR8
Srivastava R; Hernández-Ruiz M; Khan AA; Fouladi MA; Kim GJ; Ly VT; Yamada T; Lam C; Sarain SAB; Boldbaatar U; Zlotnik A; Bahraoui E; BenMohamed L
J Immunol; 2018 Apr; 200(8):2915-2926. PubMed ID: 29549178
[TBL] [Abstract][Full Text] [Related]
11. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2.
Zhao X; Deak E; Soderberg K; Linehan M; Spezzano D; Zhu J; Knipe DM; Iwasaki A
J Exp Med; 2003 Jan; 197(2):153-62. PubMed ID: 12538655
[TBL] [Abstract][Full Text] [Related]
12. Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-γ Production.
McMaster SR; Wilson JJ; Wang H; Kohlmeier JE
J Immunol; 2015 Jul; 195(1):203-9. PubMed ID: 26026054
[TBL] [Abstract][Full Text] [Related]
13. Tissue-resident T cell-derived cytokines eliminate herpes simplex virus-2-infected cells.
Roychoudhury P; Swan DA; Duke E; Corey L; Zhu J; Davé V; Spuhler LR; Lund JM; Prlic M; Schiffer JT
J Clin Invest; 2020 Jun; 130(6):2903-2919. PubMed ID: 32125285
[TBL] [Abstract][Full Text] [Related]
14. Optimal Generation of Tissue-Resident but Not Circulating Memory T Cells during Viral Infection Requires Crosspriming by DNGR-1
Iborra S; Martínez-López M; Khouili SC; Enamorado M; Cueto FJ; Conde-Garrosa R; Del Fresno C; Sancho D
Immunity; 2016 Oct; 45(4):847-860. PubMed ID: 27692611
[TBL] [Abstract][Full Text] [Related]
15. Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms.
Dobbs ME; Strasser JE; Chu CF; Chalk C; Milligan GN
J Virol; 2005 Dec; 79(23):14546-54. PubMed ID: 16282454
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection.
Johnson AJ; Nelson MH; Bird MD; Chu CF; Milligan GN
J Reprod Immunol; 2010 Jan; 84(1):8-15. PubMed ID: 19942296
[TBL] [Abstract][Full Text] [Related]
17. Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs.
Xia J; Veselenak RL; Gorder SR; Bourne N; Milligan GN
PLoS One; 2014; 9(12):e114652. PubMed ID: 25485971
[TBL] [Abstract][Full Text] [Related]
18. A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy.
Mo A; Musselli C; Chen H; Pappas J; Leclair K; Liu A; Chicz RM; Truneh A; Monks S; Levey DL; Srivastava PK
Vaccine; 2011 Nov; 29(47):8530-41. PubMed ID: 21767588
[TBL] [Abstract][Full Text] [Related]
19. Cutting Edge: The Use of Topical Aminoglycosides as an Effective Pull in "Prime and Pull" Vaccine Strategy.
Gopinath S; Lu P; Iwasaki A
J Immunol; 2020 Apr; 204(7):1703-1707. PubMed ID: 32122994
[TBL] [Abstract][Full Text] [Related]
20. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
Milligan GN; Bernstein DI
Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
